NKGen Biotech Inc. Made Big Gain
NKGen Biotech Inc. (NKGN:NASDAQ) shot up at $1.83, representing a gain of 98.5%. On Wed, Mar 06, 2024, NKGN:NASDAQ touched a New 2-Week High of $1.83. The stock appeared on our News Catalysts scanner on Wed, Mar 06, 2024 at 08:39 AM in the 'BIOTECH' category. From Thu, Feb 22, 2024, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Wed, Mar 06, 2024 at $4.06 with a volume of 105M+.
About NKGen Biotech Inc. (NKGN:NASDAQ)
NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat...
Top 10 Gainers:
- Aptorum Group Limited (APM:NASDAQ), 468.26%
- BiomX Inc. (PHGE:NYSEMKT), 197.66%
- Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
- Trxade Group, Inc. (MEDS:NASDAQ), 114.68%
- NKGen Biotech Inc. (NKGN:NASDAQ), 98.52%
- New Horizon Aircraft Ltd. (HOVR:NASDAQ), 76.92%
- Rail Vision Ltd. (RVSN:NASDAQ), 59.9%
- Nexalin Technology Inc. (NXL:NASDAQ), 57.58%
- MingZhu Logistics Holdings Limited (YGMZ:NASDAQ), 47.31%
- HCM Acquisition Corp (HCMA:NASDAQ), 46.86%